昂利康拟定增募资不超11.6亿元 用于创新药研发及产业化项目

Core Viewpoint - The company, Anglikang (002940.SZ), has announced a plan to issue A-shares to specific investors in 2025, aiming to raise 1.16 billion yuan for innovative drug research and industrialization projects [1] Group 1 - The company plans to issue shares to no more than 35 specific investors [1] - The issuance price will be no less than 80% of the average stock price over the 20 trading days prior to the pricing benchmark [1] - The total number of shares issued will not exceed 30% of the company's total share capital before the issuance, amounting to a maximum of 60.5185 million shares [1] Group 2 - The total funds to be raised through this issuance are set at 1.16 billion yuan [1] - The funds will be allocated specifically for "innovative drug research and industrialization projects" [1]